Inocras Achieves ISO 15189 Accreditation
Inocras Inc., renowned for its expertise in whole genome sequencing and bioinformatics, has achieved an impressive milestone by securing the ISO 15189 accreditation from the ANSI ASQ National Accreditation Board (ANAB). This recognition places Inocras among an elite group of global laboratories offering CAP, CLIA, and ISO 15189 accredited whole genome sequencing services specifically tailored for cancer diagnosis and treatment.
Understanding ISO 15189 Accreditation
The ISO 15189 standard represents a set of guidelines established by the International Organization for Standardization. It aims to ensure that medical laboratories meet the highest standards of quality and competence. The accreditation process emphasizes key factors such as patient safety and defined quality requirements, ensuring laboratories can deliver precise and reliable results.
Importance of This Accreditation
The ANAB medical testing accreditation program is designed to bolster the functionality of medical testing facilities, thus enhancing the quality of patient care. By using the ISO 15189 standard as a framework, laboratories are guided to prioritize patient well-being and build trust in their testing capabilities.
Global Recognition for ISO 15189
ISO 15189 is recognized worldwide and has been shaped by contributions from a broad range of medical, scientific, and clinical experts. This comprehensive framework sets forth the requirements needed for diagnostic laboratories to prove their capacity to provide timely, accurate, and dependable laboratory results.
Inocras: Committed to Quality
The achievement of ISO 15189 accreditation for Inocras is a culmination of over a year of dedicated work and cross-functional collaboration. According to Stephanie Ferguson, the Chief Clinical Operations Officer, the company utilized its already established CAP/CLIA foundations to bolster quality improvements across its operations. “Quality is everyone’s responsibility, and our dedication to providing outstanding laboratory services is paramount,” Ferguson stated.
Innovation in Bioinformatics
Beyond achieving this significant accreditation, Inocras is also paving the way for groundbreaking advancements in genomic data utilization. The company’s proprietary, IP-protected bioinformatics pipeline is integral in delivering its whole genome sequencing services, which include specialized products like CancerVision and RareVision. These are specifically designed to address the needs of cancer patients and those afflicted with rare diseases.
Research and Development Partnerships
Inocras is also intently focused on serving pharmaceutical and biotechnology companies by providing essential research services through its accredited CAP/CLIA laboratory. Their commitment to advancing precision health through whole genome data is clear, as they strive to deliver critical insights for enhanced patient outcomes.
About Inocras Inc.
Inocras Inc. is an AI-driven healthcare company dedicated to harnessing genomic data for improved patient care, particularly in cancer and rare diseases. Their innovative approaches and rigorous quality standards align with their mission to ensure all patients receive top-tier medical insights and treatment options. For further information about their services and initiatives, visit their official website at inocras.com or connect on their LinkedIn page.
Frequently Asked Questions
What is ISO 15189 accreditation?
ISO 15189 accreditation is a standard that ensures medical laboratories meet the highest quality and competence requirements in diagnostic testing.
Why is Inocras Inc. significant in the field of genomics?
Inocras is significant due to its unique whole genome sequencing capabilities which are CAP/CLIA and ISO 15189 accredited, making it a leader in cancer genomics.
How does ISO 15189 benefit patient care?
This accreditation enhances laboratory quality, leading to more accurate results, which ultimately improves patient diagnosis and treatment options.
What services does Inocras provide?
Inocras offers whole genome sequencing and bioinformatics services, alongside research support for pharmaceutical and biotechnology companies.
What is the mission of Inocras Inc.?
The mission of Inocras is to unlock the potential of genomic data to enable precision health for everyone, enhancing patient care in critical areas.
